Lockdown in Vijayawada from June 26 owing to COVID-case rise

▴ Lockdown in Vijayawada from June 26 owing to COVID-case rise
Collector also urges residents of Vijayawada to get essentials needed for an entire week before June 26

Vijayawada in Andhra Pradesh's Krishna district is going to be under the effect of an entire lockdown for seven days starting June 26. This was imminent in light of the rising number of confirmed novel Coronavirus cases in parts of the district.
As per the statement of Krisha District Collector Md Imtiaz, only essential services are going to be allowed in Vijayawada between June 26 and July 2. He further added that only medical shops are going to be permitted to open during this lockdown period.
In his statement, the Collector also urged residents of Vijayawada to get essentials needed for an entire week before June 26. This order, Md Imtiaz said, also will apply to both government and privately-owned offices in Vijayawada.

The Andhra Pradesh Health Department in its daily COVID briefing on Tuesday said that the State has 9,834 confirmed cases of infection. As many as 5,123 of those cases are active while 4,592 patients are discharged after they recovered. The infection, added officials, has claimed 119 lives in Andhra Pradesh so far.

Earlier on Tuesday, an identical decision was made by the Assam government. consistent with an order issued by Chief Secretary Kumar Sanjay Krishna, a complete lockdown came into effect in 11 wards of Guwahati starting 9 pm on Tuesday. This lockdown will continue until further orders.
In a statement, Assam Chief Secretary Kumar Sanjay Krishna was reportedly quoted as saying, "It has been reported to me by District Magistrate, Kamrup Metropolitan that there's large scale spread of COVID-19 affected cases among the overall residents of certain areas of Guwahati City which has posed as a serious threat to public health, hygiene, and safety of the overall population."
That Maharashtra, Delhi and Tamil Nadu have the highest burden of COVID-19 cases in India are understood. except for a previous couple of days, Telangana has been witnessing a troubling spike. On June 21, it recorded 730 new cases-- the fourth highest after the three worst-affected states.
With a complete of 7,800 cases till June 21, Telangana, with a population of 35 million people, remains an extended way from the foremost affected states. With 210 cases per million population, it's not even among states with alarmingly high COVID burden.
But over the last week, Telangana has seen an enormous rise in infections and it now has the fastest doubling rate for any Indian state with a minimum of 1,000 cases. Cases are now doubling every 11 days in Telangana, as against 13 in Delhi, 17 in Tamil Nadu, and 24 in Maharashtra.
Until May 25, Telangana never had each day with over 100 cases. Then on June 6, it hit 200 cases. Now, over five days between June 17 and June 21, Telangana has added nearly 2,400 cases or a 3rd of its total incidence.
Telangana’s epidemic is predominantly in Hyderabad, which had 5,512 of the state’s 7,802 cases, and has seen an alarming rise in the week. Daily new cases within the capital have grown from 189 on June 15 to 659 on June 21.

Tags : #Coronavirus #Covid19 #Vijayawada #Telangana #Lockdown

Related Stories

02 Apr

DCDC’s $150 Crore Expansion: Can Innovative Clinics End India's Kidney Crisis?

As the healthcare landscape evolves, initiatives like these will determine the future of medical care in the country.

View
26 Mar

Delhi Finally Joins Ayushman Bharat But Is It Too Late to Fix Its Healthcare Crisis?

The success of this policy shift will be measured not by announcements or budget numbers, but by real improvements in healthcare delivery.

View
01 Mar

India’s Pharma Revolution: Can New Regulatory Reforms Unleash a $42 Billion Industry?

The potential rewards are enormous a robust, efficient, and competitive pharmaceutical industry that not only fuels domestic growth but also serves as a reliable supplier of essential medicines to the world.

View
27 Feb

India’s Newborns Are Dying from Sepsis And No One Is Talking About It

Newborn sepsis is a complex problem that requires innovative solutions. More funding for research on rapid diagnostic tests, alternative treatments is essential to tackle this growing crisis.

View
26 Feb

The Corporate Invasion of Indian Hospitals: What It Means for You

The question remains: will India’s hospital sector continue on its current trajectory and become a global leader in healthcare, or will the challenges of cost, infrastructure, and regulatory hurdles slow down this remarkable journey.

View
24 Feb

The Great Indian Medical Education Paradox: More Seats, Fewer Students, Collapsing System

The NMC’s strategy to allow non-medical faculty and offer incentives for non-clinical PG courses may help in the short term, but a broader shift in how medical education is structured is necessary.

View
24 Feb

The Dark Side of India’s Pharma Boom: How Banned Drugs Found a New Market in West Africa

Stricter regulations, greater transparency, and proactive enforcement are the only ways to ensure that India’s “pharmacy of the world” reputation is built on trust and safety, not on scandals and cover-ups.

View
21 Feb

India vs. Trump’s Pharma Tariff: The Battle Over Affordable Medicine

Indian pharmaceutical companies may suffer short-term financial setbacks, but they hold the upper hand, because the U.S. needs Indian generics more than India needs the U.S. market.

View
19 Feb

Public Hospitals Go High-Tech: AIIMS Delhi Leads India’s Robotic Surgery Wave

AIIMS sets a precedent for other hospitals across India to follow. If robotic surgery becomes more widespread, the dream of world-class healthcare for all Indians may not be as distant as it once seemed.

View
19 Feb

Tata’s ₹500-Crore Gamble: Is Healthcare the New Playground for India’s Corporate Giants?

As India’s healthcare sector continues to evolve, corporate giants like Tata are not just participants but key drivers of change.

View

-Advertisements-




Trending Now

Moscow Center for Diagnostics and Telemedicine Receives License for Radiology Residency ProgramApril 02, 2025
CARE Hospitals Launches AI-Powered Non-Invasive Therapy – An innovative modality introduced in Telangana & Andhra PradeshApril 02, 2025
High-Rise Heart Attacks: Are Skyscrapers Turning Survival into a Race Against Time?April 02, 2025
DCDC’s $150 Crore Expansion: Can Innovative Clinics End India's Kidney Crisis?April 02, 2025
Medanta Rolls Out ‘Colon Tunnel on Wheels’ to Drive Awareness on Colorectal Cancer Prevention & Early DetectionApril 01, 2025
Zigly launches 2 pet hospitals, opens 4 new stores; expects ARR to more than double in 1-2 yearsApril 01, 2025
University of Leeds Announces International Masters Regional Scholarships for 2025April 01, 2025
Avantor Recognized with Two Prestigious Awards at Asia-Pacific Biopharma Excellence Awards 2025April 01, 2025
Foundation Stone Laid for Madhav Netralaya Eye Hospital & Research CentreApril 01, 2025
Doomscrolling at Midnight: How Indians Are Sacrificing Sleep for ScreensMarch 31, 2025
Essential Medicines Price Surge: Are Patients Paying the Price?March 31, 2025
Prioritize your health during the holy days of RamzanMarch 31, 2025
Tired of Stomach Cramps? These Simple Foods Can Heal Your GutMarch 31, 2025
Regional growth booming for startups in 2024 - QBO Innovation studyMarch 31, 2025
Is long-acting HIV treatment as good as taking daily pills?March 31, 2025
Right to safe abortion cannot be dislocated from human rightsMarch 28, 2025
Popeyes® Opens Third Store in Hyderabad at Inorbit MallMarch 28, 2025
Popeyes® Opens Third Store in Hyderabad at Inorbit MallMarch 28, 2025
10 New HIV Cases in 2 Months: Has Kerala’s Drug Problem Gone Too Far?March 28, 2025
Type 2 Diabetes Under Attack: The Unexpected Power of Wearable TechMarch 28, 2025